Evidence map›Paper›PMID 32081491›Full record

ArticleOphthalmology2020

Artificial Intelligence Classification of Central Visual Field Patterns in Glaucoma.

Mengyu Wang, Lucy Q Shen, Louis R Pasquale, Michael V Boland, Sarah R Wellik, Carlos Gustavo De Moraes, Jonathan S Myers, Thao D Nguyen, Robert Ritch, Pradeep Ramulu and 5 more

Open access · greenAbstract read
In one paragraph

Article in Ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Mengyu WangSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Lucy Q ShenMassachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Louis R PasqualeEye and Vision Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Michael V BolandWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Sarah R WellikBascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida.
Carlos Gustavo De MoraesEdward S. Harkness Eye Institute, Columbia University Medical Center, New York, New York.
Jonathan S MyersWills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Thao D NguyenDepartment of Mechanical Engineering, Johns Hopkins University, Baltimore, Maryland.
Robert RitchEinhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai, New York, New York.
Pradeep RamuluWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Hui WangSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; Institute for Psychology and Behavior, Jilin University of Finance and Economics, Changchun, China.
Jorryt TichelaarSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Dian LiSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Peter J BexDepartment of Psychology, Northeastern University, Boston, Massachusetts.
Tobias ElzeSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; Complex Structures in Biology and Cognition, Max Planck Institute for Mathematics in the Sciences, Leipzig, Germany. Electronic address: tobias-elze@tobias-elze.de.
Massachusetts Eye and Ear Infirmary · USJohns Hopkins University · USBrigham and Women's Hospital · USColumbia University Irving Medical Center · USNew York Eye and Ear Infirmary · USNortheastern University · USThomas Jefferson University · USUniversity of Miami · US

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Tobias Elze · 1985 to 2026
$25.5M
Gene-Environment Interactions in GlaucomaR01EY015473 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI PASQUALE, LOUIS ROBERT · 2005 to 2021
$8.3M
Personalizing Glaucoma Diagnosis by Disease Specific Patterns and Individual Eye AnatomyR01EY030575 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI ELZE, TOBIAS · 2019 to 2023
$2.4M
Structural and Functional Progression of Glaucomatous Damage to the MaculaR01EY025253 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DE MORAES, CARLOS GUSTAVO · 2015 to 2017
$1.2M
Role of Capillary Flow and Autoregulation in Primary Open Angle GlaucomaK23EY025014 · NEI · UNIVERSITY OF MARYLAND BALTIMORE · PI SAEEDI, OSAMAH JAWAID · 2015 to 2019
$1.0M
Associating retinal nerve fiber layer thickness with glucose metabolism and diabetic retinopathyR21EY030631 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI ELZE, TOBIAS · 2019 to 2020
$554k
Improved Glaucoma Monitoring Using Artificial-Intelligence Enabled DashboardR21EY031725 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI YOUSEFI, SIAMAK · 2020 to 2022
$545k
A hybrid artificial intelligence framework for glaucoma monitoringR21EY030142 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ELZE, TOBIAS, YOUSEFI, SIAMAK · 2019 to 2020
$499k
Relationship between Glaucoma and the Three-Dimensional Optic Nerve Head Related StructureK99EY028631 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI WANG, MENGYU · 2019 to 2020
$293k
NEI NIH HHS K23 EY025014NEI NIH HHS K99 EY028631NEI NIH HHS P30 EY003790NEI NIH HHS R01 EY015473NEI NIH HHS R01 EY025253NEI NIH HHS R01 EY030575NEI NIH HHS R21 EY030142NEI NIH HHS R21 EY030631NEI NIH HHS R21 EY031725
6 · The paper itself

Abstract

purposeTo quantify the central visual field (VF) loss patterns in glaucoma using artificial intelligence.

designRetrospective study.

participantsVFs of 8712 patients with 13 951 Humphrey 10-2 test results from 13 951 eyes for cross-sectional analyses, and 824 patients with at least 5 reliable 10-2 test results at 6-month intervals or more from 1191 eyes for longitudinal analyses.

methodsTotal deviation values were used to determine the central VF patterns using the most recent 10-2 test results. A 24-2 VF within a 3-month window of the 10-2 tests was used to stage eyes into mild, moderate, or severe functional loss using the Hodapp-Anderson-Parrish scale at baseline. Archetypal analysis was applied to determine the central VF patterns. Cross-validation was performed to determine the optimal number of patterns. Stepwise regression was applied to select the optimal feature combination of global indices, average baseline decomposition coefficients from central VFs archetypes, and other factors to predict central VF mean deviation (MD) slope based on the Bayesian information criterion (BIC).

main outcome measuresThe central VF patterns stratified by severity stage based on 24-2 test results and a model to predict the central VF MD change over time using baseline test results.

resultsFrom cross-sectional analysis, 17 distinct central VF patterns were determined for the 13 951 eyes across the spectrum of disease severity. These central VF patterns could be divided into isolated superior loss, isolated inferior loss, diffuse loss, and other loss patterns. Notably, 4 of the 5 patterns of diffuse VF loss preserved the less vulnerable inferotemporal zone, whereas they lost most of the remaining more vulnerable zone described by the Hood model. Inclusion of coefficients from central VF archetypical patterns strongly improved the prediction of central VF MD slope (BIC decrease, 35; BIC decrease of >6 indicating strong prediction improvement) than using only the global indices of 2 baseline VF results. Eyes with baseline VF results with more superonasal and inferonasal loss were more likely to show worsening MD over time.

conclusionsWe quantified central VF patterns in glaucoma, which were used to improve the prediction of central VF worsening compared with using only global indices.

Indexed as

Artificial IntelligenceAgedBayes TheoremCross-Sectional StudiesFemaleGlaucomaHumansIntraocular PressureMaleMiddle AgedRetrospective StudiesVision DisordersVisual FieldsVisual Field Tests

Identifiers

PMID32081491
PMCPMC7246163
OpenAlexW2995814342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.